Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.

Li, Yiwen

Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure. [electronic resource] - Journal of cardiac failure Mar 2007 - 155-62 p. digital

Publication Type: Journal Article

1532-8414

10.1016/j.cardfail.2006.11.005 doi


Angiotensin II Type 1 Receptor Blockers--therapeutic use
Animals
Antihypertensive Agents--therapeutic use
Blood Urea Nitrogen
Blotting, Western
Creatinine--blood
DNA--genetics
Disease Models, Animal
Heart Failure--drug therapy
Immunohistochemistry
Kidney Failure, Chronic--complications
Male
Matrix Metalloproteinase 2--biosynthesis
Matrix Metalloproteinase 9--biosynthesis
Mice
Mice, Inbred C57BL
Mice, Knockout
Myocardium--metabolism
Nephrectomy--adverse effects
Oxidative Stress--genetics
Receptor, Angiotensin, Type 1--blood
Signal Transduction--physiology
Tetrazoles--therapeutic use
Tissue Inhibitor of Metalloproteinase-1--genetics
Transforming Growth Factor beta1--biosynthesis
Treatment Outcome
Up-Regulation--drug effects
Valine--analogs & derivatives
Valsartan
Ventricular Function, Left--drug effects